Registry of the molekularen tumor boards of the University Cancer Centers Schleswig-Holstein (short title: „UCCSH-MTB-registry)
Recruiting
- Conditions
- solid tumors and hematologic neoplasiaC00-C97Malignant neoplasms
- Registration Number
- DRKS00028806
- Lead Sponsor
- niversitätsklinikum Schleswig-Holstein, Lübeck Klinik für Hämatologie und Onkologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
Referral to the molecular tumor board
Exclusion Criteria
informed consent not signed
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Determination of the potential benefit of presenting to the Molecular Tumor Board when no therapy option according to clinical guidelines remains/ exists.
- Secondary Outcome Measures
Name Time Method - Determination of the rate of therapy-relevant molecular markers associated with the molecular diagnostic method used.<br>- Documentation of previously undescribed aberrations within and across tumor entities. <br>- Documentation of the frequency of previously known driver mutations in rare tumor entities.<br>- Gaining knowledge through documentation of therapy response and outcome of individual healing attempts as a basis for therapy recommendations in future cases with similar initial situation.